Novel Therapeutic Strategies for Depression

Authors

  • Suhina Sharma
  • Matthew Gostkowski
  • Jay Patel
  • Christina Yang

Keywords:

Depression, Antidepressants, Ketamine, Psilocybin, Glutamate, NMDA receptor, 5-HT2A receptor

Abstract

Depression is a complex neurological disorder that has many potential causes and treatment approaches. Though there are many conventional antidepressants available in the market, it is becoming increasingly difficult to rely on them as many patients may experience a lack of effectiveness or tolerance to these antidepressants. While current antidepressants increase serotonin and norepinephrine concentrations through reuptake inhibition, novel forms of antidepressants rely on the direct manipulation of receptors, thereby also improving neuroplasticity, which has emerged as a promising approach to treating depressive symptoms. In this literature review, various forms of novel antidepressants are analyzed. The mechanisms studied are Psilocybin’s long-term success, Ketamine’s rapid action, hormonal treatments’ direct targeted approach, and natural products’ reduction of neurotoxic side effects. Understanding how these powerful mechanisms work may allow for the research and creation of more effective antidepressants in the future.

Downloads

Download data is not yet available.

Downloads

Published

2022-12-28

How to Cite

Sharma, S., Gostkowski, M., Patel, J., & Yang, C. (2022). Novel Therapeutic Strategies for Depression. Berkeley Pharma Tech Journal of Medicine, 2(2), 20–47. Retrieved from https://berkeleypharmatechjournalofmedicine.com/index.php/bptjm/article/view/30

Issue

Section

Scientific Review Papers